2016
DOI: 10.1038/srep19995
|View full text |Cite
|
Sign up to set email alerts
|

miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1

Abstract: Drug resistance is one of the leading causes of failed cancer therapy in the treatment of acute myeloid leukemia. Although the mechanisms of resistance are poorly understood, they may be related to the presence of leukemia stem cells (LSCs). Down-regulation of the miR-203 reportedly contributes to oncogenesis and chemo-resistance in multiple cancers. We found that miR-203 expression was down-regulated in CD34 + AML cells as compared with CD34− cells isolated from patients as well as in LSC-enriched (CD34 + CD3… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
36
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(36 citation statements)
references
References 43 publications
0
36
0
Order By: Relevance
“…Zhang et al reported that miR-203 downregulation frequently occurred in CD34 + AML cells in relation to CD34 − cells isolated from patients. Additionally, re-expression of miR-203 inhibited cell proliferation, self-renewal, and sphere formation in LSCs by targeting survivin and Bmi-1 [37].…”
Section: Micrornamentioning
confidence: 99%
“…Zhang et al reported that miR-203 downregulation frequently occurred in CD34 + AML cells in relation to CD34 − cells isolated from patients. Additionally, re-expression of miR-203 inhibited cell proliferation, self-renewal, and sphere formation in LSCs by targeting survivin and Bmi-1 [37].…”
Section: Micrornamentioning
confidence: 99%
“…86,87 CD34 marker expression in AML is reported to be associated with poor prognosis and apoptosis-resistance markers. [88][89][90] Interestingly, CD34 fractions derived from AML samples with higher percentages of CD34 cells are more resistant to apoptosis than those derived from samples with a low CD34 percentage. In addition, apoptosis-related proteins are found to be differentially expressed among these populations, 91 showing higher expression of antiapoptotic proteins such as Bcl-2 and Bcl-xL in CD34 pos vs CD34 neg subpopulations.…”
mentioning
confidence: 99%
“…As validated by qPCR ( Fig. 5a), stemness-inhibiting miRNAs, e.g., miR-203 and the miR-200 family (miR-200a, 200b, 200c, 141, and 429) 39,40 were markedly decreased in 16B/TNF compared to HOK-16B cells. Normal and cancer stem cells have reduced expression of miR-200 family members and miR-203, which results in increased expression of the stem cell factors.…”
Section: Resultsmentioning
confidence: 79%
“…For instance, miR-203 and the miR-200 family (miR-200a, 200b, 200c, 141, and 429) were downregulated in CSCs isolated from various cancer types, and their regulation could alter CSC markers and properties, indicating that they are CSC-inhibiting miRNAs. 39,40,54 miR-203 suppresses CSCs by targeting Bmi-1. 39 miR-200 members inhibit CSC self-renewal and properties by suppressing Notch signaling.…”
Section: Discussionmentioning
confidence: 99%